Two national pandemics – COVID-19 and racism – have highlighted inequities in medication use in the United States. These inequities often translate to poorer health outcomes in communities that already have barriers to optimal health. While the evidence documenting these disparities is abundant, systemic solutions remain elusive.
The 28th Pharmaceutical Outcomes and Policy seminar will examine how optimal medication use differs by race and ethnicity and what underlying factors confound this relationship. Experts will discuss imperatives for increasing diversity in clinical trials, removing access barriers, and enhancing data and measures. Finally, industry leaders will share examples of incremental progress made through real-world programs and propose systemic strategies to combat racial inequities in medication use
Upon successful completion of this course, the student will be able to:
- Describe the relationship between inequities in medication use and patient health outcomes.
- Analyze factors confounding the relationship between medication use and race and ethnicity.
- Discuss barriers to equitable medication use.
- Propose systematic strategies to reduce racial inequities in medication use
*Please note that this syllabus is subject to change. Use the updated syllabus in Canvas as the official course syllabus.